Cell Viability & Health
Our team of experts specializes in providing you with high-quality assays to assess the viability, health, and overall function of your cells, and help to optimize your drug candidates. You can expect fast, reliable, and accurate testing services that deliver high-quality data to meet pre-clinical demands. Our assays for cell viability and health are a mix of microscopy imaging and plate reader assays, and in some cases can be run in either format.
Services Offered
Cell Viability Assays
-
Metabolic Activity, MTT
-
Metabolic Activity, ATP
-
Cytotoxicity, LDH
-
Live/Dead Cell Stains
Apoptosis Assays
-
TUNEL
-
Annexin V
-
Caspase Activity
Other Cell Death Assays
-
Necroptosis
-
Necrosis
-
Pyroptosis
-
Ferroptosis
Cell Stress Assays
-
ER Stress
-
Autophagy, LC3B
DNA Damage Assays
-
Ames Test
-
COMET SCGE Assay
-
ICC for PAR Polymer (PARG inhibition)
-
ICC for γ-H2AX
-
ICC for 53BP1
Mitochondrial Health
-
Abundance, Localization, Dynamics
-
Oxidative Stress
-
Membrane Potential
-
Mitophagy: TOMM20 Loss
Cell Cycle Assays
-
ICC for Cell Cycle Analysis
-
ICC for Centrosome Analysis
-
ICC for Proliferation
-
Senescence
Services Offered for Other Endpoint Assays
ICC for HDAC6
Inhibition
LAT1
Inhibition
ICC for β-Catenin Nuclear
Translocation
TGFβ/
SMAD
Viral
tittering
Case Study
Advancing Cancer Therapeutics Through Targeted PARG Inhibition: A Case Study
Note: This case study is to be used in conjunction with the PowerPoint file titled:
Conventional Assays - Cell Viability - DNA Damage - ICC for PAR Polymer (PARG Inhibition).pptx
Chadwick Davis
Senior Manager Research and Pharmaceutical Project Team Lead
Therapeutics Accelerator - University of Utah
Working with CROs often means navigating the challenges of offshore operations, which, while cost-effective, can lack in going the extra mile and speed. Scintillant, on the other hand, may have a narrower scope, but their efficiency is unmatched. Their local presence combined with their ability to deliver results in just a week at times is a testament to their dedication and agility.
Alex Stark
Senior Manager Research
Therapeutics Accelerator - University of Utah
Choosing Scintillant Bioscience was a game-changer. Their local, easy, and convenient approach combined with their fast and reliable services is unmatched. For startups like ours, they cut down a lot of front-end time, making them perfect for proof of concept. They provide early advantages essential for budding teams and concepts. Truly, their nimbleness sets them apart.
▲ ICC for beta-catenin nuclear translocation